Phasebio Pharmaceuticals Inc. (PHAS) Return on Investment ROI from the second quarter of 2022 to second quarter of 2021 and for the year 2022, average high and low, overall ranking from Jun 30 2022 to Jun 30 2021 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Phasebio Pharmaceuticals Inc.  (NASDAQ: PHAS)


Phasebio Pharmaceuticals's ROI from its second quarter of 2022 to the second quarter of 2021 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Phasebio Pharmaceuticals's ROI in the second quarter of 2022?
Phasebio Pharmaceuticals Inc. recorded a cumulative net loss of $-103 million during 12 months ending in the second quarter of 2022, resulting in a negative return on investment (ROI) of -397.88%.

Within the Healthcare sector 1059 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2022 from 0 to 5239.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter		 (Dec 31 2021)
IV. Quarter		 (Sep 30 2021)
III. Quarter		 (Jun 30 2021)
II. Quarter
Y / Y Investment Change TTM -58.01 % -10.62 % 29.23 % 8.64 % -8.92 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions -3 17 33 56 84
Return On Investment (TTM) - -241.34 % -204.71 % -183.96 % -181.24 %
PHAS's Overall Ranking # 5239 # 0 # 0 # 0 # 0
Seq. Investment Change TTM -45.69 % -25.67 % -0.46 % 4.51 % 15.6 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -103 -115 -131 -118 -112

PHAS Company Profile >> Back to PHAS Roi Comparisons >> See Annual PHAS Return On Investment



Return On Investment PHAS's Ranking
Within: No.
Industry # 517
Sector # 1060
Overall # 5239

Return On Investment Statistics
High Average Low
-28.29 %
-151.93 %
-382.73 %
(Sep 30 2019)   (Jun 30 2022)







Financial Statements
Phasebio Pharmaceuticals's II. Quarter Investments $ -3 Millions PHAS's Balance sheet
Phasebio Pharmaceuticals's II. Quarter Income $ -17 Millions Quarterly PHAS's Income Statement
PHAS's Income by Division See PHAS's Income by Division


PHAS Annual Return On Investment (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018
Total Investments in Millions 33 34 73 58 0
Y / Y Investment Growth -3.52 % -53.32 % 24.05 % - -
Net Income in Millions -131 -99 -39 -24 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment -401.36 % -291.19 % -54.13 % -40.8 % -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
PHAS's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for PHAS's Competitors
Subscribers only: Roi for Phasebio Pharmaceuticals's Suppliers
Subscribers only: Return On Investment for PHAS's Customers

Other Ratios
PHAS's Roa PHAS's Inventory Turnover Ratio PHAS's Growth Rates PHAS's Dividend Statistics
PHAS's Profitability Ratios PHAS's Asset Turnover Ratio PHAS's Dividend Growth
PHAS's Roe PHAS's Valuation Ratios PHAS's Financial Strength Ratios PHAS's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2022, within Healthcare Sector ROI

Date modified: 2026-09-26T07:35:42+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.